DSGNBeen watching DSGN set up over the past few days and wanted to break down how I approached this one
This wasn’t a random entry — the bigger picture showed a clear uptrend with higher lows, and price was pushing into a key resistance zone around $10.40–$11.20. That told me this was either going to break out or reject, so I waited for structure to guide the entry.
At open we saw strength push toward $11.20, but instead of chasing, I waited for a pullback and started building a position between $10.35$10.42, giving me an average around $10.41
The idea here was:
→ Buy the pullback into support within an uptrend
→ Let the breakout attempt develop
→ Manage risk if the level fails
Key levels I’m watching:
Upside:
→ $11.00–$11.20 = breakout / decision zone
→ If we break and hold above, that opens room toward $12.50+
Downside / risk:
→ $10.20-10.40 = key support
As low as 10$
→ If this level 1020-10.40 fails clean, that signals a failed breakout test and I’ll reassess and prob exit and wait for better postion
Right now price is sitting right at that decision area, so this is where patience matters. I’m not chasing just letting price confirm whether it wants to continue higher or pull back further.
Big takeaway on this one:
→ Don’t chase strength at the top
→ Wait for pullbacks within structure
→ Enter where your risk is clearly defined
Clean setups like this don’t need to be forced — just executed properly
Design Therapeutics, Inc.
No trades
No trades
In-depth trading ideas
$DSGN - Russell 2000 WholesaleWholesale Area: $2 -$8
Retail Area: $22 -$25
Golden Ratio: $45
Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease.
$DSNG Gap Fill$DSNG had Director 10% - George Simeon buy 900,000 shares on Dec. 20, 2022 and Rodney Lappe, DIR bought 112,024 shares on December 9, 2022. This tells me they are bullish about their company. I also see the MACD sellers cooling and some nice volume coming in. Many are at the $8.06 level and the $16 level. I will wait for the MACD to cross for an entry. But the blue lines are entry and exit points based from support and resistance.
$DSGN is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea
Design Therapeutics is a biotechnology company developing a platform of gene targeted chimera (GeneTAC™) small molecules for the treatment of serious degenerative disorders caused by inherited nucleotide repeat expansions.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $29,32;
stop-loss — $19, 40 ;
take-profit — 23,49/MOC price.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.



